BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1479 related articles for article (PubMed ID: 19810674)

  • 1. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
    Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
    J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipophilicity plays a major role in modulating the inhibition of monoamine oxidase B by 7-substituted coumarins.
    Carotti A; Altomare C; Catto M; Gnerre C; Summo L; De Marco A; Rose S; Jenner P; Testa B
    Chem Biodivers; 2006 Feb; 3(2):134-49. PubMed ID: 17193252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches.
    Catto M; Nicolotti O; Leonetti F; Carotti A; Favia AD; Soto-Otero R; Méndez-Alvarez E; Carotti A
    J Med Chem; 2006 Aug; 49(16):4912-25. PubMed ID: 16884303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoamine oxidase.
    Leonetti F; Capaldi C; Pisani L; Nicolotti O; Muncipinto G; Stefanachi A; Cellamare S; Caccia C; Carotti A
    J Med Chem; 2007 Oct; 50(20):4909-16. PubMed ID: 17824599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
    Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.
    Matos MJ; Viña D; Picciau C; Orallo F; Santana L; Uriarte E
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5053-5. PubMed ID: 19628387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Befani O; Turini P; Giovannini V; Mondovì B; Cirilli R; La Torre F
    J Med Chem; 2004 Apr; 47(8):2071-4. PubMed ID: 15056004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors.
    Shi L; Yang Y; Li ZL; Zhu ZW; Liu CH; Zhu HL
    Bioorg Med Chem; 2010 Feb; 18(4):1659-64. PubMed ID: 20117937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of monoamine oxidases by coumarin-3-acyl derivatives: biological activity and computational study.
    Chimenti F; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3697-703. PubMed ID: 15203146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
    La Regina G; Silvestri R; Artico M; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
    J Med Chem; 2007 Mar; 50(5):922-31. PubMed ID: 17256833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors.
    Pisani L; Catto M; Nicolotti O; Grossi G; Di Braccio M; Soto-Otero R; Mendez-Alvarez E; Stefanachi A; Gadaleta D; Carotti A
    Eur J Med Chem; 2013; 70():723-39. PubMed ID: 24231308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors.
    Matos MJ; Terán C; Pérez-Castillo Y; Uriarte E; Santana L; Viña D
    J Med Chem; 2011 Oct; 54(20):7127-37. PubMed ID: 21923181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.
    Secci D; Carradori S; Bolasco A; Chimenti P; Yáñez M; Ortuso F; Alcaro S
    Eur J Med Chem; 2011 Oct; 46(10):4846-52. PubMed ID: 21872365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
    Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
    Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple, potent, and selective pyrrole inhibitors of monoamine oxidase types A and B.
    Silvestri R; La Regina G; De Martino G; Artico M; Befani O; Palumbo M; Agostinelli E; Turini P
    J Med Chem; 2003 Mar; 46(6):917-20. PubMed ID: 12620068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of species-dependent differences on screening, design, and development of MAO B inhibitors.
    Novaroli L; Daina A; Favre E; Bravo J; Carotti A; Leonetti F; Catto M; Carrupt PA; Reist M
    J Med Chem; 2006 Oct; 49(21):6264-72. PubMed ID: 17034132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
    Gallardo-Godoy A; Fierro A; McLean TH; Castillo M; Cassels BK; Reyes-Parada M; Nichols DE
    J Med Chem; 2005 Apr; 48(7):2407-19. PubMed ID: 15801832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
    Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins.
    Santana L; Uriarte E; González-Díaz H; Zagotto G; Soto-Otero R; Méndez-Alvarez E
    J Med Chem; 2006 Feb; 49(3):1149-56. PubMed ID: 16451079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins.
    Chimenti F; Secci D; Bolasco A; Chimenti P; Bizzarri B; Granese A; Carradori S; Yáñez M; Orallo F; Ortuso F; Alcaro S
    J Med Chem; 2009 Apr; 52(7):1935-42. PubMed ID: 19267475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.